Bayer is stepping away from the $670 million CAR-T worldwide license agreement it entered with Atara Biotherapeutics in 2020.

As Europe and North America face a potential monkeypox outbreak, Danish biotech Bavarian Nordic has won a contract to supply its smallpox vaccine to an unnamed European...

Cytiva, the former biopharma activities of General Electric and now part of Danaher, will open a new manufacturing facility in Grens, Switzerland, on May 31. Operations...

The European Commission has indicated it may cancel an advance purchase agreement with Valneva that calls for the France-headquartered biotech to supply 60 million doses...

EureKING, a new special purpose acquisition company (SPAC) steered by former European biopharma executives, launched itself on May 9 and in a subsequent listing on the...

Wacker Chemie has opened a new US regional innovation center in Ann Arbor, Michigan, dedicated to developing high-margin biotech and silicone specialties for high-tech...

Major drugmaker Pfizer has agreed to buy US biotech Biohaven Pharmaceutical for around $11.6 billion. Founded in 2013 and based in New Haven, Connecticut, Biohaven...

Interview with Joachim Haupt and Florian Kaiser, PharmAI

Asia-Pacific contract research organization (CRO) Novotech has acquired NCGS, a US CRO with about 300 employees and a biopharma client base. Financial terms of the...

Interview with Giovanna Libralon, Senior Director Commercial Development Small Molecules at Lonza.